Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

avantor

Optimise your clinical trials with Avantor Clinical Services

December 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Campaign, Avantor, clinical trials, expertise

Serious diseases like COVID-19 put increasing pressure on researchers to find breakthrough treatments faster. Along with accelerated timelines, biopharma and …
News
moderna_norwood_plant

Analysis confirms Moderna’s COVID-19 vaccine efficacy to be 94.1%

November 30, 2020 Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

US biotech Moderna has followed up on its highly promising efficacy data for its mRNA-based COVID-19 vaccine candidate with the …
News
lilly_building_with_american_flag_web

Canada secures 26,000 doses of Lilly therapy to treat COVID-19 in $32.5m deal

November 25, 2020 Manufacturing and Production, Research and Development COVID-19, Canada

The Canadian Government has partnered up with Eli Lilly to secure 26,000 doses of the company’s monoclonal antibody therapy bamlanivimab …
News
flu_vaccination_grippe_5115654021_5

Largest clinical trial treating mild to moderate COVID-19 patients to take place in Africa

November 25, 2020 Research and Development

The world’s largest clinical trial investigating the treatment of patients with mild to moderate COVID-19 is set to begin in …
News
1200px-eurotunnel_11

ABPI warns that no-deal Brexit could disrupt medicines and vaccine delivery

November 25, 2020 Research and Development

The Association of the British Pharmaceutical Industry (ABPI) has warned that the supplies of crucial medicines and vaccines could be …
News
1200px-oxycontin_branded_oxycodone_10mg_oc_side

Purdue Pharma pleads guilty to its role in the opioid crisis

November 25, 2020 Research and Development

Purdue Pharma has pleaded guilty to criminal charges over its role in fueling the opioid crisis which was driven by …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 25, 2020 Research and Development

The coronavirus news this week sees more companies release their coronavirus vaccine results, with Pfizer and BioNTech backing up their …
News
pharmafocus_december_2020_cover

The December 2020 issue of Pharmafocus is available to read free online now!

November 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …
News
vaccination-1215279_960_720

Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show

November 24, 2020 Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …
News

Sanofi’s invasive meningococcal disease vaccine approved for EU use in four serotypes

November 23, 2020 Research and Development, Sales and Marketing

Sanofi’s MenQuadfi combination vaccine has secured approval from the European Commission for the prevention of invasive meningococcal disease caused by …
News
dado_ruvic-illustration-reuters

Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy

November 23, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine

Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …
News
gilead-sciences

Gilead’s lenacapavir meets primary goal in heavily treated and multidrug resistant HIV-1

November 19, 2020 Research and Development Gilead, HIV, pharma

Gilead has pulled back the curtain on promising new data for its long-acting HIV-1 capsid inhibitor lenacapavir for heavily treated …
News

OPEN Health reveals new CEO appointment

November 19, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …
News
bristol_myers_squibb_moreton_wirral_-_img_0369

Bristol Myers Squibb completes $13.1 billion acquisition of MyoKardia

November 18, 2020 Research and Development

Bristol Myers Squibb has announced that its acquisition of MyoKardia has been completed, with the transaction worth a total of …
News
lilly_building_with_american_flag_web

NICE recommends Lilly’s Emgality for chronic and episodic migraine

November 18, 2020 Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK

Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026